Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents

Affiliations

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
² Division of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, Tennessee.
³ Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois.
⁴ Simmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, Texas.
⁵ Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia.
⁶ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. Electronic address: aijazahmed@stanford.edu.

George Cholankeril et al. Clin Gastroenterol Hepatol. 2018 Mar.

. 2018 Mar;16(3):452-453.

doi: 10.1016/j.cgh.2017.08.020. Epub 2017 Aug 31.

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
² Division of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, Tennessee.
³ Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois.
⁴ Simmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, Texas.
⁵ Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia.
⁶ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. Electronic address: aijazahmed@stanford.edu.

No abstract available

MeSH terms